<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药研 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-01T16:25:22+08:00</updated>
  <subtitle>药研是一个药物研发领域专业的公共咨询服务平台。2016年成立之初即为广大制药领域同仁积极提供国内外专业的药物研究、注册相关资讯，获得广泛赞誉！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-01T16:13:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/02gKatzO2IMi-Ue7xUtRLA</id>
    <link href="https://mp.weixin.qq.com/s/02gKatzO2IMi-Ue7xUtRLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国新药研发的几个窗口期：药企的机会也是时代的缩影</title>
    <updated>2020-12-01T16:13:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/ZNw1q5AI3qrjpN3c3Z4NGA</id>
    <link href="https://mp.weixin.qq.com/s/ZNw1q5AI3qrjpN3c3Z4NGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE原首席科学家徐增军：创新药要“研”“发”并重，并积极推动研发全球化</title>
    <updated>2020-12-01T16:13:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/Yo9TZRCXRD81YHU1_q-3ug</id>
    <link href="https://mp.weixin.qq.com/s/Yo9TZRCXRD81YHU1_q-3ug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都先导董事长李进：国内新药研发与国际差距缩小 但应避免同质化竞争</title>
    <updated>2020-12-01T16:13:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/dzUWBDwaN4G73di0SNDjJg</id>
    <link href="https://mp.weixin.qq.com/s/dzUWBDwaN4G73di0SNDjJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>到2022年珠三角居民有望用上香港澳门上市药品</title>
    <updated>2020-12-01T16:13:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/cqeptqEi2sthkAbO_PyNVg</id>
    <link href="https://mp.weixin.qq.com/s/cqeptqEi2sthkAbO_PyNVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>男人福音｜江苏恒瑞他达拉非片获批上市</title>
    <updated>2020-11-30T17:38:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/JVsIa-w0xlnWRl16j6NRCA</id>
    <link href="https://mp.weixin.qq.com/s/JVsIa-w0xlnWRl16j6NRCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE新增14条一般性技术技术问题解答</title>
    <updated>2020-11-30T17:38:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/T54WVh1iMLLPqbgxuB7SiQ</id>
    <link href="https://mp.weixin.qq.com/s/T54WVh1iMLLPqbgxuB7SiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药专家灵魂砍价，厂家都要被急哭了</title>
    <updated>2020-11-28T22:53:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/Oy7IENekRg_pwX9vaUpXdw</id>
    <link href="https://mp.weixin.qq.com/s/Oy7IENekRg_pwX9vaUpXdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局药品审评中心原首席科学家徐增军：创新药要“研”“发”并重，并积极推动研发全球化</title>
    <updated>2020-11-28T22:53:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/UrBh7ByJss7D62sb7Ezpmw</id>
    <link href="https://mp.weixin.qq.com/s/UrBh7ByJss7D62sb7Ezpmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医生为何都喜欢用沙坦类药降血压，到底是哪里好？此文为您讲清楚</title>
    <updated>2020-11-28T22:53:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/cIZ93Lv5kGOEmRU_ypEdOw</id>
    <link href="https://mp.weixin.qq.com/s/cIZ93Lv5kGOEmRU_ypEdOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【更新版】药品技术转移、工艺验证和清洁验证最新要求与合规操作</title>
    <updated>2020-11-28T18:07:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/JEL45DNhVHJDySMMyspNeQ</id>
    <link href="https://mp.weixin.qq.com/s/JEL45DNhVHJDySMMyspNeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】2020药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-11-28T18:07:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/ElInKGIfqP98vTa57IdELA</id>
    <link href="https://mp.weixin.qq.com/s/ElInKGIfqP98vTa57IdELA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【翻译服务】佳鑫医药服务之药学翻译</title>
    <updated>2020-11-28T18:07:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/SP9eQDEVANx0cRfQ5NKmMw</id>
    <link href="https://mp.weixin.qq.com/s/SP9eQDEVANx0cRfQ5NKmMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【干货】遗传毒性杂质风险评估简析</title>
    <updated>2020-11-27T15:53:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/mITFCUhRD0As8PUOiXNjrg</id>
    <link href="https://mp.weixin.qq.com/s/mITFCUhRD0As8PUOiXNjrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】2020药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-11-27T15:53:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/dVYYfyolSBpi1YLkMFsSpA</id>
    <link href="https://mp.weixin.qq.com/s/dVYYfyolSBpi1YLkMFsSpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】药品技术转移、工艺验证和清洁验证最新要求与合规操作专题培训</title>
    <updated>2020-11-27T15:53:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/N1xDssiW4Z6KevficgADUA</id>
    <link href="https://mp.weixin.qq.com/s/N1xDssiW4Z6KevficgADUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】药品技术转移、工艺验证和清洁验证最新要求与合规操作专题培训</title>
    <updated>2020-11-26T11:31:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/eu4oS5KygEZBLE0q2fkcQA</id>
    <link href="https://mp.weixin.qq.com/s/eu4oS5KygEZBLE0q2fkcQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新版药典，各省实施细节不尽相同</title>
    <updated>2020-11-26T11:31:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/2NNtmcjmamxDUL6jHBWN3A</id>
    <link href="https://mp.weixin.qq.com/s/2NNtmcjmamxDUL6jHBWN3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浙江知名药企出售子公司​</title>
    <updated>2020-11-26T11:31:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/6d86gr3rG4PDGu_TssWhlA</id>
    <link href="https://mp.weixin.qq.com/s/6d86gr3rG4PDGu_TssWhlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚｜CDE发布《药品审评中心补充资料工作程序（试行）》的通告</title>
    <updated>2020-11-25T16:31:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/ijk5s4P2EXCtFsYmCYCSaw</id>
    <link href="https://mp.weixin.qq.com/s/ijk5s4P2EXCtFsYmCYCSaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>